—These investigators compared criteria from the two commonly used pathologic risk classification systems for endometrial carcinoma, assessed their concordance with molecular subtypes, and evaluated ...

This transcript has been edited for clarity. For more episodes, download the Medscape app or subscribe to the podcast on Apple Podcasts, Spotify, or your preferred podcast provider. Gini F. Fleming, ...

For women with pelvic recurrences of grade 1 or 2 endometrial cancer, adding cisplatin to definitive radiation treatment may result in more acute toxicities and no clinical benefit. These patients can ...